Cited by 197Mitochondrial Function and PathologyMuscle Physiology and DisordersAdipose Tissue and Metabolism

The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index; 33 of the 331 sources its claims cite were checked for support.

The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass

Open access
Romanello, Vanina, Sandri, Marco·2021·Cellular and Molecular Life Sciences

Abstract

The dynamic coordination of processes controlling the quality of the mitochondrial network is crucial to maintain the function of mitochondria in skeletal muscle. Changes of mitochondrial proteolytic system, dynamics (fusion/fission), and mitophagy induce pathways that affect muscle mass and performance. When muscle mass is lost, the risk of disease onset and premature death is dramatically increased. For instance, poor quality of muscles correlates with the onset progression of several age-related disorders such as diabetes, obesity, cancer, and aging sarcopenia. To date, there are no drug therapies to reverse muscle loss, and exercise remains the best approach to improve mitochondrial health and to slow atrophy in several diseases. This review will describe the principal mechanisms that control mitochondrial quality and the pathways that link mitochondrial dysfunction to muscle mass regulation.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review synthesizes how mitochondrial quality-control pathways—proteostasis, fusion/fission dynamics, and mitophagy—are mechanistically coupled to the regulation of skeletal muscle mass. It argues that dysregulation of any of these interconnected systems triggers catabolic signaling (notably via AMPK–FoxO3, ATF4, and FGF21) that feeds forward to muscle atrophy, while balanced mitochondrial remodeling preserves muscle and whole-body homeostasis.

Key findings

  • Mitochondrial quality control operates through coordinated systems: mitochondrial proteases (LONP1, ClpP, m-AAA, YME1L1, OMA1, PARL), the UPS/MAD pathway (p97/VCP), UPRmt, mitochondrial dynamics (MFN1/2, OPA1 for fusion; DRP1, MFF, MiD49/51 for fission), MDVs, and mitophagy (PINK1/Parkin-dependent and Parkin-independent receptors BNIP3, NIX, FUNDC1, Bcl2-L-13). A Drosophila proteomic study cited found ~70% of mitochondrial protein turnover occurs via non-autophagic processes, with mitophagy accounting for the remaining ~one third.
  • Muscle-specific deletion of fusion proteins causes severe phenotypes: MFN1/MFN2 double knockout mice die within 6–8 weeks with mtDNA depletion and point mutations; OPA1 deletion in adult mice (3–5 months) reduces mtDNA, respiratory complexes/supercomplexes, and membrane potential, causing atrophy, weakness, systemic inflammation, epithelial senescence, and premature death (rescued by FGF21 co-deletion). OPA1 overexpression protects against denervation- and COX15-deletion-induced muscle loss.
  • Fission is also required: DRP1 overexpression activates atrophy via AMPK–FoxO3 and the eIF2α–ATF4–FGF21 axis; DRP1 ablation in adult muscle causes muscle loss with mitophagy impairment, MCU upregulation, calcium overload, ER stress, and FGF21 induction. PUM2-mediated repression of MFF increases with age; PUM2 deletion in old mice raises MFF, enhances fission/mitophagy, and improves mitochondrial function and lifespan.
  • Unbalanced dynamics are more deleterious than simultaneous reduction of both: OPA1/DRP1 double knockout mice show a less severe phenotype than OPA1 knockout alone, with transient FGF21 elevation and rescued lethality. FGF21 is commonly induced across OPA1-null, DRP1-null, and DKO models but with different magnitudes and outcomes (dose-dependent: moderate = adaptive, dramatic = detrimental).

Methods

  • Narrative review; no primary experimental data. Synthesizes mechanistic cell-biology literature and mouse/human genetic models of mitochondrial quality control and muscle atrophy.
  • Covers human disease genetics (CMT2A from MFN2 mutations, DOA from OPA1 mutations, DRP1/MFF/MiD49 mutations, VCP-associated myopathy) and rodent conditional knockout/transgenic models (muscle-specific MFN1/2, OPA1, DRP1, DKO, PUM2, ATG5/7, VPS15, etc.).
  • Includes a summary table (Table 1) comparing signaling and phenotype of muscle-specific Opa1-, Drp1-, and Drp1/Opa1-null mice at early (70 days) and late (365 days) post-deletion.

Limitations

  • The paper is a review and states no formal limitations of its own; it repeatedly notes open questions, e.g., that IMJ molecular composition and function "have to be defined," that the IMM fission machinery players remain largely unidentified, and that MDV biogenesis machinery is unknown.
  • Evident from the text: several mechanistic conclusions rest on in vitro data whose in vivo physiological relevance "needs to be validated" (e.g., p62/optineurin/NDP52 mitophagy receptor data), and some findings are described as controversial (e.g., MARCHV/MITOL effects on DRP1 vary by cell context).
  • Evident from the text: many causal inferences about muscle mass come from constitutive or conditional knockout mouse models with embryonic lethality or early death, which may not fully represent adult physiological remodeling.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00018-020-03662-0

Cites

246 of 246 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Mitochondria quality control pathways. a The mitochondrial proteases LONP1, ClpP, OMA1, YME1L1, and PARL maintained mitochondrial proteostasis. PARL, OMA1, and YME1L1 process OPA1 protein, critical for mitochondrial fusion and cristae remodeling. PARL degrades PINK1, regulating mitophagy. b Mitochondrial fusion is mediated by MFN1/2 and OPA1 to produce an elongated mitochondrial network. c DRP1 and MFF are the major proteins involved in mitochondrial fission. Fragmented mitochondria with low ΔΨm are removed by mitophagy. d BNIP3 and NIX are mitophagy receptors that bind to LC3 to tether mitochondria to the autophagosome. PINK1 accumulates on of depolarized mitochondria surface, where it phosphorylates ubiquitinated OMM proteins and the Parkin UBL domain. Parkin will further promote the ubiquitination of the outer mitochondrial membrane proteins. Then, the ubiquitinated proteins can be recognized by the p62/SQSTM1 adaptor, to initiate mitophagy. e Mild mitochondrial damage activates the release of mitochondrial-derived vesicles (MDVs) containing mitochondrial components for their degradation in the lysosome
Fig. 1 Mitochondria quality control pathways. a The mitochondrial proteases LONP1, ClpP, OMA1, YME1L1, and PARL maintained mitochondrial proteostasis. PARL, OMA1, and YME1L1 process OPA1 protein, critical for mitochondrial fusion and cristae remodeling. PARL degrades PINK1, regulating mitophagy. b Mitochondrial fusion is mediated by MFN1/2 and OPA1 to produce an elongated mitochondrial network. c DRP1 and MFF are the major proteins involved in mitochondrial fission. Fragmented mitochondria with low ΔΨm are removed by mitophagy. d BNIP3 and NIX are mitophagy receptors that bind to LC3 to tether mitochondria to the autophagosome. PINK1 accumulates on of depolarized mitochondria surface, where it phosphorylates ubiquitinated OMM proteins and the Parkin UBL domain. Parkin will further promote the ubiquitination of the outer mitochondrial membrane proteins. Then, the ubiquitinated proteins can be recognized by the p62/SQSTM1 adaptor, to initiate mitophagy. e Mild mitochondrial damage activates the release of mitochondrial-derived vesicles (MDVs) containing mitochondrial components for their degradation in the lysosomeCC BY · PubMed Central
Fig. 2 Mitochondria-derived signaling pathways controlling muscle mass and whole-body homeostasis. a Increased fission or decreased fusion leads to dysfunctional fragmented organelles, which activate the energy sensor AMPK by increasing the AMP/ATP ratio, ROS production, and the inflammatory response. P-AMPK directly phosphorylates FoxO3 increasing its transcriptional activity and affecting muscle mass. ROS production causes endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR). UPR induces the ATF4-dependent upregulation of FGF21 secreted by the muscle that contributes to muscle loss, causes a systemic metabolic shift, and premature senescence. b Balanced mitochondrial fusion and fission are critical for muscle function and whole-body homeostasis. c A reduction of mitochondrial fusion results in the accumulation of elongated dysfunctional mitochondria resulting in mitophagy impairment, loss of ER tethering, ER stress, increased mitochondrial calcium overload, and decreased cytosolic calcium causing cell death, muscle loss, and weakness. Dashed lines indicate mechanisms that need more studies
Fig. 2 Mitochondria-derived signaling pathways controlling muscle mass and whole-body homeostasis. a Increased fission or decreased fusion leads to dysfunctional fragmented organelles, which activate the energy sensor AMPK by increasing the AMP/ATP ratio, ROS production, and the inflammatory response. P-AMPK directly phosphorylates FoxO3 increasing its transcriptional activity and affecting muscle mass. ROS production causes endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR). UPR induces the ATF4-dependent upregulation of FGF21 secreted by the muscle that contributes to muscle loss, causes a systemic metabolic shift, and premature senescence. b Balanced mitochondrial fusion and fission are critical for muscle function and whole-body homeostasis. c A reduction of mitochondrial fusion results in the accumulation of elongated dysfunctional mitochondria resulting in mitophagy impairment, loss of ER tethering, ER stress, increased mitochondrial calcium overload, and decreased cytosolic calcium causing cell death, muscle loss, and weakness. Dashed lines indicate mechanisms that need more studiesCC BY · PubMed Central

Verification

Claims the paper makes

178 Not checked yet · 46 No basis given · 30 Own interpretation · 11 Partly supported · 5 Supported · 1 Supported so far · 1 Mixed support · accuracy not yet measured

Verify all 298 references — free account

Show all 134 claims

  • It may state two separate claims as one. 116
  • Probably not a substantial claim. 30
138 of 138
  • The paper relies on this without support.

    Mitochondrial dysfunction is linked to muscle function loss in age-related metabolic disorders such as diabetes, obesity, cancer, and aging sarcopenia.

    “Mitochondrial dysfunction has been linked to muscle function loss that occurs in several age-related metabolic disorders such as diabetes, obesity, cancer, and aging sarcopenia.”
  • The paper relies on this without support.

    Loss of muscle mass increases the risk of disease onset and premature death.

    “When muscle mass is lost, the risk of disease onset and premature death is dramatically increased.”
  • The paper relies on this without support.

    Skeletal muscle is a post-mitotic tissue whose cells do not divide, so damaged or dysfunctional mitochondria cannot be diluted through cellular division.

    “Skeletal muscle is a post-mitotic tissue. Its cells do not divide, and consequently, damaged/dysfunctional mitochondria cannot be diluted through cellular division.”
  • The paper relies on this without support.

    Under physiological conditions, mitochondrial fusion and fission are balanced to control mitochondrial morphology, size, and number.

    “Under physiological conditions, fusion and fission processes are balanced to control mitochondrial morphology, size, and number.”
  • The paper relies on this without support.

    Excessive activation or impairment of either fusion or fission alters the balance and compromises mitochondrial function and cell health.

    “However, an excessive activation or the impairment of either fusion or fission alter the balance and compromise mitochondrial function and cell health.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 246 references

Cited by

Sorted by citations

See all 197

Metadata

Authors
Romanello, V., & Sandri, M.
Affiliations
University of Padua (IT)
Corresponding author
  • Romanello, Vanina
  • Sandri, Marco
Venue
Cellular and Molecular Life Sciences
Published
2020-10-19
Volume
78
Issue
4
Pages
1305-1328
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W3093074122
Cited by
197
References
246
Citations by year
2026: 23 · 2025: 28 · 2024: 40 · 2023: 44 · 2022: 36 · 2021: 25 · 2020: 1
FWCI
2.54
Type
journal article
Language
en
Open access
Locations
  • Cellular and Molecular Life Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
  • AFM-Téléthon (22457)
  • STARSCOG
  • Associazione Italiana per la Ricerca sul Cancro
  • Università degli Studi di Padova
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
mitochondrial network dynamics, mitochondrial fission, mitochondrial fusion, mitophagy, mitochondrial proteolysis, skeletal muscle mass, muscle atrophy, sarcopenia, mitochondrial quality control, physical activity, mitochondrial dysfunction, age-related muscle loss
MeSH terms
Aging, Humans, Mitochondria, Muscular Diseases, Muscle, Skeletal, Proteolysis, Mitochondrial Dynamics, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review